Abstract | PURPOSE: METHODS: We conducted a prospective cohort study on treatment of neurocysticercosis in Tanzania between August 2018 and January 2022. Patients were initially treated with albendazole (15 mg/kg/d) for 10 days and followed up for 6 months. Additionally in July 2021, all participants who then still had cysts were offered a combination therapy consisting of albendazole (15 mg/kg/d) and praziquantel (50 mg/kg/d). Antiparasitic treatment was accompanied by corticosteroid medication and anti-seizure medication if the patient had experienced epileptic seizures before treatment. RESULTS: Sixty-three patients were recruited for this study, of whom 17 had a complete follow-up after albendazole monotherapy. These patients had a total of 138 cysts at baseline, of which 58 (42%) had disappeared or calcified by the end of follow-up. The median cyst reduction was 40% (interquartile range 11-63%). Frequency of epileptic seizures reduced considerably (p < 0.001). Three patients had all active cysts resolved or calcified and of the remaining 14, eight received the combination therapy which resolved 63 of 66 cysts (95%). Adverse events were infrequent and mild to moderate during both treatment cycles. CONCLUSION:
|
Authors | D Stelzle, C Makasi, V Schmidt, C Trevisan, I Van Damme, C Ruether, P Dorny, P Magnussen, G Zulu, K E Mwape, E Bottieau, C Prazeres da Costa, U F Prodjinotho, H Carabin, E Jackson, A Fleury, S Gabriël, B J Ngowi, A S Winkler |
Journal | Infection
(Infection)
Vol. 51
Issue 4
Pg. 1127-1139
(Aug 2023)
ISSN: 1439-0973 [Electronic] Germany |
PMID | 36961623
(Publication Type: Journal Article)
|
Copyright | © 2023. The Author(s). |
Chemical References |
- Albendazole
- Antiparasitic Agents
- Praziquantel
- Anthelmintics
|
Topics |
- Humans
- Neurocysticercosis
(drug therapy, complications, parasitology)
- Albendazole
(adverse effects)
- Antiparasitic Agents
(adverse effects)
- Praziquantel
(adverse effects)
- Tanzania
- Prospective Studies
- Cysts
(chemically induced, complications, drug therapy)
- Seizures
(drug therapy, chemically induced, complications)
- Anthelmintics
(adverse effects)
|